Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
PEGFILGRASTIM
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP2/3CCC (54)
pf-08634404
Small Cell Lung Carcinoma
PfizerP2/3CCC (54)
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION
Early-Onset Autosomal Dominant Alzheimer Disease
Nelly PitteloudP2/3CCC (54)
rp2
Uveal Melanoma
Replimune, Inc.P2/3CCC (54)
Sls-005
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MDP2/3CCC (54)
Solanezumab
Familial Alzheimer Disease
Washington University School of MedicineP2/3CCC (54)
Sonazoid
Melanoma
The Netherlands Cancer InstituteP2/3CCC (54)
Troriluzole
Glioblastoma
Ugonma ChukwuekeP2/3CCC (54)
Tucidinostat
Leukemia
The First Affiliated Hospital of Xiamen UniversityP2/3CCC (54)
Ublituximab
Follicular Lymphoma
City of Hope Medical CenterP2/3CCC (54)
Uliledlimab
Non-Small Cell Lung Carcinoma
TJ Biopharma Co., Ltd.P2/3CCC (54)
Vebreltinib
Glioblastoma
Huashan HospitalP2/3CCC (54)
VEMURAFENIB
Glioma
Cancer Research UKP2/3CCC (54)
xy03-ea
Ischemic Stroke
Shijiazhuang Yiling Pharmaceutical Co. LtdP2/3CCC (54)
BICALUTAMIDE
Ovarian Cancer
Gynaecologisch Oncologisch Centrum ZuidP2/3CCC (53)
Nelarabine
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (53)
Nktr-255
Non-Hodgkin Lymphoma
Nektar TherapeuticsP2/3CCC (53)
Nktr-255
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Nektar TherapeuticsP2/3CCC (53)
Osivelotor
Sickle Cell Disease
PfizerP2/3CCC (53)
Solanezumab
Dementia
Washington University School of MedicineP2/3CCC (53)
Ublituximab
Mantle Cell Lymphoma
Yazeed SawalhaP2/3CCC (53)
1.0% ip-001 for
Colorectal Cancer
Immunophotonics, Inc.P2/3CCC (52)
1.0% ip-001 for
Rectal Carcinoma
Immunophotonics, Inc.P2/3CCC (52)
[18f]f-resca-rt4
Urinary Bladder Carcinoma
RenJi HospitalP2/3CCC (52)
[18f]f-resca-rt4
Cholangiocarcinoma
RenJi HospitalP2/3CCC (52)
Showing 826 to 850 of 1,055 assets
PreviousPage 34 of 43Next